1899 related articles for article (PubMed ID: 26597926)
41. Advantages of renin-angiotensin system blockade in the treatment of cardiovascular diseases.
Gerc V; Buksa M
Med Arh; 2010; 64(5):295-9. PubMed ID: 21287956
[TBL] [Abstract][Full Text] [Related]
42. Renin angiotensin system inhibitors for patients with stable coronary artery disease without heart failure: systematic review and meta-analysis of randomized trials.
Bangalore S; Fakheri R; Wandel S; Toklu B; Wandel J; Messerli FH
BMJ; 2017 Jan; 356():j4. PubMed ID: 28104622
[TBL] [Abstract][Full Text] [Related]
43. Estimated Lifetime Benefit of Combined RAAS and SGLT2 Inhibitor Therapy in Patients with Albuminuric CKD without Diabetes.
Vart P; Vaduganathan M; Jongs N; Remuzzi G; Wheeler DC; Hou FF; McCausland F; Chertow GM; Heerspink HJL
Clin J Am Soc Nephrol; 2022 Dec; 17(12):1754-1762. PubMed ID: 36414316
[TBL] [Abstract][Full Text] [Related]
44. Should all patients at high cardiovascular risk receive renin-angiotensin system blockers?
Volpe M
QJM; 2012 Jan; 105(1):11-27. PubMed ID: 22011630
[TBL] [Abstract][Full Text] [Related]
45. Multicentre randomized controlled trial of angiotensin-converting enzyme inhibitor/angiotensin receptor blocker withdrawal in advanced renal disease: the STOP-ACEi trial.
Bhandari S; Ives N; Brettell EA; Valente M; Cockwell P; Topham PS; Cleland JG; Khwaja A; El Nahas M
Nephrol Dial Transplant; 2016 Feb; 31(2):255-61. PubMed ID: 26429974
[TBL] [Abstract][Full Text] [Related]
46. Renin-angiotensin system inhibitors in hypertensive adults with non-diabetic CKD with or without proteinuria: a systematic review and meta-analysis of randomized trials.
Mishima E; Haruna Y; Arima H
Hypertens Res; 2019 Apr; 42(4):469-482. PubMed ID: 30948820
[TBL] [Abstract][Full Text] [Related]
47. Risk of pneumonia associated with use of angiotensin converting enzyme inhibitors and angiotensin receptor blockers: systematic review and meta-analysis.
Caldeira D; Alarcão J; Vaz-Carneiro A; Costa J
BMJ; 2012 Jul; 345():e4260. PubMed ID: 22786934
[TBL] [Abstract][Full Text] [Related]
48. Rationale for combination angiotensin receptor blocker and angiotensin-converting enzyme inhibitor treatment and end-organ protection in patients with chronic kidney disease.
Toto R; Palmer BF
Am J Nephrol; 2008; 28(3):372-80. PubMed ID: 18073461
[TBL] [Abstract][Full Text] [Related]
49. Renin angiotensin system blockade and cardiovascular outcomes in patients with chronic kidney disease and proteinuria: a meta-analysis.
Balamuthusamy S; Srinivasan L; Verma M; Adigopula S; Jalandhara N; Hathiwala S; Smith E
Am Heart J; 2008 May; 155(5):791-805. PubMed ID: 18440325
[TBL] [Abstract][Full Text] [Related]
50. Mega clinical trials which have shaped the RAS intervention clinical practice.
Düsing R
Ther Adv Cardiovasc Dis; 2016 Jun; 10(3):133-50. PubMed ID: 27271312
[TBL] [Abstract][Full Text] [Related]
51. Effects of calcium channel blockers comparing to angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in patients with hypertension and chronic kidney disease stage 3 to 5 and dialysis: A systematic review and meta-analysis.
Lin YC; Lin JW; Wu MS; Chen KC; Peng CC; Kang YN
PLoS One; 2017; 12(12):e0188975. PubMed ID: 29240784
[TBL] [Abstract][Full Text] [Related]
52. Can ACE inhibitors and angiotensin receptor blockers be detrimental in CKD patients?
Onuigbo MA
Nephron Clin Pract; 2011; 118(4):c407-19. PubMed ID: 21389735
[TBL] [Abstract][Full Text] [Related]
53. Effects of blood pressure lowering on outcome incidence in hypertension: 4. Effects of various classes of antihypertensive drugs--overview and meta-analyses.
Thomopoulos C; Parati G; Zanchetti A
J Hypertens; 2015 Feb; 33(2):195-211. PubMed ID: 25485720
[TBL] [Abstract][Full Text] [Related]
54. ACE inhibitors, angiotensin receptor blockers and direct renin inhibitors in combination: a review of their role after the ONTARGET trial.
Düsing R; Sellers F
Curr Med Res Opin; 2009 Sep; 25(9):2287-301. PubMed ID: 19635044
[TBL] [Abstract][Full Text] [Related]
55. Diabetes mellitus as a compelling indication for use of renin angiotensin system blockers: systematic review and meta-analysis of randomized trials.
Bangalore S; Fakheri R; Toklu B; Messerli FH
BMJ; 2016 Feb; 352():i438. PubMed ID: 26868137
[TBL] [Abstract][Full Text] [Related]
56. The Validity of Left Ventricular Mass as a Surrogate End Point for All-Cause and Cardiovascular Mortality Outcomes in People With CKD: A Systematic Review and Meta-analysis.
Badve SV; Palmer SC; Strippoli GFM; Roberts MA; Teixeira-Pinto A; Boudville N; Cass A; Hawley CM; Hiremath SS; Pascoe EM; Perkovic V; Whalley GA; Craig JC; Johnson DW
Am J Kidney Dis; 2016 Oct; 68(4):554-563. PubMed ID: 27138469
[TBL] [Abstract][Full Text] [Related]
57. Summary of AHRQ's comparative effectiveness review of angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers added to standard medical therapy for treating stable ischemic heart disease.
White CM; Greene L
J Manag Care Pharm; 2011 Jun; 17(5 Suppl):S1-15. PubMed ID: 21780334
[TBL] [Abstract][Full Text] [Related]
58. Comparative effectiveness of angiotensin receptor blockers vs. angiotensin-converting enzyme inhibitors on cardiovascular outcomes in patients initiating peritoneal dialysis.
Shen JI; Saxena AB; Montez-Rath ME; Leng L; Chang TI; Winkelmayer WC
J Nephrol; 2017 Apr; 30(2):281-288. PubMed ID: 27485007
[TBL] [Abstract][Full Text] [Related]
59. Cost-effectiveness of angiotensin-converting enzyme inhibitors versus angiotensin II receptor blockers as first-line treatment in autosomal dominant polycystic kidney disease.
Clark LA; Whitmire S; Patton S; Clark C; Blanchette CM; Howden R
J Med Econ; 2017 Jul; 20(7):715-722. PubMed ID: 28332417
[TBL] [Abstract][Full Text] [Related]
60. Angiotensin-Converting Enzyme Inhibitors or Angiotensin Receptor Blockers in Patients Without Heart Failure? Insights From 254,301 Patients From Randomized Trials.
Bangalore S; Fakheri R; Toklu B; Ogedegbe G; Weintraub H; Messerli FH
Mayo Clin Proc; 2016 Jan; 91(1):51-60. PubMed ID: 26763511
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
